|Syntax and speech|
WE Cooper, J Paccia-Cooper
Harvard University Press, 1980
|Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body|
P Ashton, RA Patchell, J Cooper, BA Young
US Patent 5,836,935, 1998
|Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion|
JD Cooper, A Salehi, JD Delcroix, CL Howe, PV Belichenko, ...
Proceedings of the National Academy of Sciences 98 (18), 10439-10444, 2001
|Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development|
TM Michaelidis, M Sendtner, JD Cooper, MS Airaksinen, B Holtmann, ...
Neuron 17 (1), 75-89, 1996
|Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat|
J Cornwall, JD Cooper, OT Phillipson
Brain research bulletin 25 (2), 271-284, 1990
|Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation|
TT Yeo, J Chua-Couzens, LL Butcher, DE Bredesen, JD Cooper, ...
Journal of Neuroscience 17 (20), 7594-7605, 1997
|Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age-and dose-dependent fashion|
JC Mitchell, P McGoldrick, C Vance, T Hortobagyi, J Sreedharan, B Rogelj, ...
Acta neuropathologica 125 (2), 273-288, 2013
|Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus|
M da Penha Berzaghi, J Cooper, E Castren, F Zafra, M Sofroniew, ...
Journal of Neuroscience 13 (9), 3818-3826, 1993
|mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases|
M Palmieri, R Pal, HR Nelvagal, P Lotfi, GR Stinnett, ML Seymour, ...
Nature communications 8 (1), 1-19, 2017
|The neurotrophins BDNF, NT‐3 and NT‐4/5, but not NGF, up‐regulate the cholinergic phenotype of developing motor neurons|
V Wong, R Arriaga, NY Ip, RM Lindsay
European Journal of Neuroscience 5 (5), 466-474, 1993
|Targeted disruption of the Cln3 gene provides a mouse model for Batten disease|
HM Mitchison, DJ Bernard, NDE Greene, JD Cooper, MA Junaid, ...
Neurobiology of disease 6 (5), 321-334, 1999
|The relative abundance of birds on set‐aside and neighbouring fields in summer|
IG Henderson, J Cooper, RJ Fuller, J Vickery
Journal of Applied Ecology 37 (2), 335-347, 2000
|Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis|
E Bible, P Gupta, SL Hofmann, JD Cooper
Neurobiology of disease 16 (2), 346-359, 2004
|Display screen with transitional graphical user interface|
JXY Zhu, K Anderson-Barrett, CC Chi, J Cooper
US Patent App. 29/624,527, 2019
|High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease|
MR Pears, JD Cooper, HM Mitchison, RJ Mortishire-Smith, DA Pearce, ...
Journal of Biological Chemistry 280 (52), 42508-42514, 2005
|Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3|
MV Sofroniew, JD Cooper, CN Svendsen, P Crossman, NY Ip, ...
Journal of Neuroscience 13 (12), 5263-5276, 1993
|Late onset neurodegeneration in the Cln3−/− mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation|
CC Pontikis, CV Cella, N Parihar, MJ Lim, S Chakrabarti, HM Mitchison, ...
Brain research 1023 (2), 231-242, 2004
|An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease|
S Chattopadhyay, M Ito, JD Cooper, AI Brooks, TM Curran, JM Powers, ...
Human molecular genetics 11 (12), 1421-1431, 2002
|Projections to the rostral reticular thalamic nucleus in the rat|
J Cornwall, JD Cooper, OT Phillipson
Experimental brain research 80 (1), 157-171, 1990
|Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis|
M Chang, JD Cooper, DE Sleat, SH Cheng, JC Dodge, MA Passini, ...
Molecular Therapy 16 (4), 649-656, 2008